Dysentery clinical trials
The registry lists 44 studies for Dysentery across more than 10 countries. 6 are recruiting or about to start. 20 of them are mainly about Dysentery (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Dysentery, Bacillary too: 93 studies, 11 open.
Get an email when these change. Save the Dysentery studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Johns Hopkins Bloomberg School of Public Health (4) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (4) · Genzyme, a Sanofi Company (3) · Sohag University (2) · Assistance Publique - Hôpitaux de Paris (2) · PATH (2) · Centre for Infectious Disease Research in Zambia (2) · Eskisehir Osmangazi University (1)
What is being tested here
Drugs under test in Dysentery studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3, phase 3 first
- Jun 2027VE303 for Prevention of Recurrent Clostridioides Difficile Infection · Phase 3 · Vedanta Biosciences, Inc.
- Dec 2026Preventative Intervention for Cholera for 7 Days · Johns Hopkins Bloomberg School of Public Health
- Dec 2026Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7) · Johns Hopkins Bloomberg School of Public Health
Who these studies take
Of the 6 Dysentery studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 4 (67%) take children under 18. 1 (17%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (33%) | 2 (33%) |
| 18 | 4 (67%) | 3 (50%) |
| 30 | 5 (83%) | 4 (67%) |
| 40 | 5 (83%) | 4 (67%) |
| 50 | 5 (83%) | 4 (67%) |
| 65 | 5 (83%) | 4 (67%) |
| 75 | 5 (83%) | 4 (67%) |
| 85 | 5 (83%) | 4 (67%) |
Across all 44 studies, recruiting or not: 52% stop at 75 or younger and 52% at 65; 48% take children; 2% are for women only and 2% for men only; 57% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 44 of 44. search them.
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruitingNCT06237452Phase 324 countries
- Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)RecruitingNCT06498817Not applicable1 country
- The Impact of Shigellosis and Recommended Treatment in ChildrenRecruitingNCT07433426Phase 22 countries
- Preventative Intervention for Cholera for 7 DaysRecruitingNCT05166850Not applicable1 country
- Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome TrajectoriesRecruitingNCT071950061 country
- Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD PatientsRecruitingNCT05770726Not applicable1 country
- The Utility and Feasibility of Accessible Diarrhea Etiology Prediction Tool (ADEPT) in an Informal Healthcare SettingCompletedNCT07538531Not applicable1 country
- Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.CompletedNCT05933525Phase 21 country
- Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineActive, not recruitingNCT06838195Phase 31 country
- Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan HospitalCompletedNCT07257705Not applicable1 country
- Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in ChildrenCompletedNCT07342088Not applicable1 country
- Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgACompletedNCT06896136Phase 11 country
- Ciprofloxacin Versus Azithromycin for Children Hospitalised With DysenteryCompletedNCT03854929Phase 41 country
- GastroIntestinal Panel in Kidney Transplant PatientsStatus unknownNCT05722119Phase 3
- The Effectiveness of Pleuran in Treatment of Acute Gastroenteritis in ChildrenCompletedNCT03988257Phase 41 country
- Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious DiarrheaTerminatedNCT03809117Not applicable1 country
- A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in AfricaCompletedNCT043129062 countries
- Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)CompletedNCT04423159Not applicable1 country
- Concomitant Infection of Intestinal Parasites and Helicobacter PyloriStatus unknownNCT053609401 country
- Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy AdultsCompletedNCT05409196Phase 11 country
- Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ERCompletedNCT04237181Not applicable1 country
- Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years OldCompletedNCT04865497Phase 21 country
- Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 YearsStatus unknownNCT05156528Phase 31 country
- Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.Status unknownNCT047599371 country
- Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™CompletedNCT050086401 country
- Safety Study of Inactivated Shigella Whole Cell Vaccine in AdultsCompletedNCT01509846Phase 11 country
- The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) AlgorithmCompletedNCT04602676Not applicable2 countries
- Efficacy and Safety of CB-01-11 200mg Tablets in Infectious DiarrhoeaCompletedNCT03447821Phase 2
- Efficacy of Rifaximin in Preventing CampylobacteriosisCompletedNCT02280044Phase 2/31 country
- Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine CandidateCompletedNCT01080716Phase 1/21 country
- Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsCompletedNCT03561181Phase 11 country
- Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in AdultsWithdrawnNCT03038243Phase 21 country
- Improving the Quality of Private Sector Health Care in West BengalCompletedNCT02291575Not applicable
- Trial Evaluating Ambulatory Treatment of Travelers' DiarrheaTerminatedNCT01618591Not applicable5 countries
- The Effect of Probiotics on E. Coli GastroenteritisCompletedNCT01225042Not applicable1 country
- A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00382304Phase 21 country
- A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaTerminatedNCT00466635Phase 31 country
- Social Network Interventions in Rural HondurasCompletedNCT01672580Not applicable1 country
- A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00034294Phase 24 countries
- Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli InfectionsStatus unknownNCT01638039Not applicable1 country
- Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in IsraelCompletedNCT00368316Phase 31 country
- Solar Disinfection (SODIS) of Drinking Water for Use in Developing Countries or in Emergency SituationsCompletedNCT01306383Not applicable3 countries
- Solar Disinfection of Drinking WaterCompletedNCT01082107Not applicable1 country
- New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management- Surveillance Study for Adverse EffectsCompletedNCT00490932Phase 41 country